Trial intelligence / Profile preview

Post-marketing safety and effectiveness study of dapoxetine for premature ejaculation in China

CTR20140887Phase 4Completed

Sponsor
Janssen-Cilag
Start
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dapoxetine in premature ejaculation (PE), sponsored by Janssen-Cilag. Started Dec 2014; status: completed.

02

Drugs

dapoxetine
03

Conditions

premature ejaculation (PE)

Beyond the preview

Go deeper on CTR20140887.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140887.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call